Workshop on biosimilar monoclonal antibodies and immunogenicity of monoclonal antibodies

Date: 24/10/2011
Location: European Medicines Agency, London, UK
The European Medicines Agency workshop on biosimilar monoclonal antibodies is intended to discuss the draft guideline on similar biological medicinal products containing monoclonal antibodies and the guideline on immunogenicity assessment of monoclonal antibodies intended for in vivo clinical use with stakeholders who provided comments on the two guidelines during the public consultation phase. Registration closed.


How useful was this page?

Add your rating